MEDP vs NTRA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 10, 2026

MEDP

59.5
AI Score
VS
MEDP Wins

NTRA

58.4
AI Score

Investment Advisor Scores

MEDP

60score
Recommendation
HOLD

NTRA

58score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric MEDP NTRA Winner
Revenue 2.13B 2.24B NTRA
Net Income 382.69M -211.97M MEDP
Net Margin 18.0% -9.4% MEDP
Operating Income 453.87M -237.63M MEDP
ROE 65.4% -11.3% MEDP
ROA 16.6% -7.7% MEDP
Total Assets 2.30B 2.75B NTRA
Current Ratio 0.83 2.81 NTRA
Free Cash Flow 479.51M 14.65M MEDP

Relative Price Performance (Last 90 Days)

MEDP 1M: +7.2% · 3M: +11.3% NTRA 1M: -21.6% · 3M: -1.3%

Current Technical Phase

MEDP

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (3.5% over 20 days), RSI 56

RSI (14): 55.8 · Price: $664.54

NTRA

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 31

RSI (14): 30.8 · Price: $311.98

Fundamentals Snapshot

Metric MEDP NTRA
Market Cap — —
Forward P/E 33.5 -803.2
Trailing P/E 37.4 —
Revenue (TTM) — —
Revenue Growth 0.1% 0.3%
Gross Margin 0.7% 0.7%
Operating Margin 0.2% -0.1%
EPS 18.01 -1.12
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, MEDP is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.